Skip to content

Medical emergency? What to do

Genetic melanoma risk less than previously thought

3-RXPublished October 18, 20052 min read

Key points

  • The findings from a new study indicate that carriers of the CDKN2A mutation have a 28-percent lifetime risk of melanoma, much lower than the 58 percent to 91 percent risk previously identified in studies of multiple-case families.
  • The study, which is reported in the Journal of the National Cancer Institute, involved an analysis of cases of melanoma, the most serious type of skin cancer, in nine geographic regions in Australia, Canada, the United States and Italy.
  • Overall, 65 CDKN2A mutation carriers were identified.
  • "This indicates that CDNK2A mutations are rare," Begg noted.

The findings from a new study indicate that carriers of the CDKN2A mutation have a 28-percent lifetime risk of melanoma, much lower than the 58 percent to 91 percent risk previously identified in studies of multiple-case families.

"In studies of multiple-case families, these families could well be linked by other genes that contribute to the risk of melanoma as well as the one you're looking at," said lead author Dr. Colin B. Begg, from Memorial Sloan-Kettering Cancer Center in New York. "When you separate out the family history like we did in our study, you tend to see a more representative estimate of the risk."

The study, which is reported in the Journal of the National Cancer Institute, involved an analysis of cases of melanoma, the most serious type of skin cancer, in nine geographic regions in Australia, Canada, the United States and Italy.

DNA from 3,550 melanoma patients was analyzed for CDKN2A mutations. The melanoma histories of the close relatives of these patients were used to determine the lifetime risk of melanoma associated with CDKN2A mutation carrier status.

Overall, 65 CDKN2A mutation carriers were identified. The risk of developing melanoma among mutation carriers ranged from 14 percent by age 50 years to 28 percent by age 80 years.

While 18 of the melanoma patients had at least three relatives with melanoma, only one was a CDNK2A mutation carrier, according to the report.

"This indicates that CDNK2A mutations are rare," Begg noted. "So, genetic testing for the mutation is going to reveal relatively few carriers."

Begg said his team is further analyzing the data from this study to identify other potential genetic risk factors for melanoma.

SOURCE: Journal of the National Cancer Institute, October 19, 2005.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underCancer

Keep reading

Brain

Italy court ruling links mobile phone use to tumor

Italy's supreme court has upheld a ruling that said there was a link between a business executive's brain tumor and his heavy mobile phone usage, potentially opening the door to further legal claims. The court's…

2 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.